Both the univariate and multivariate regression analyses indicated that FIGO stage and BCL9 expression were significantly associated with PFS (Table 3) and OS (Table 4), suggesting that they can be used as biomarkers to independently predict prognosis in ovarian cancer patients. This evidence concerns the gene BCL9 and ovarian cancer.